Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
暂无分享,去创建一个
Andrew H. Beck | Robert J. Marinelli | R. West | M. van de Rijn | M. J. van de Vijver | A. Beck | A. Sangoi | S. Leung | R. J. Marinelli | T. Nielsen | D. Koller | Daphne Koller
[1] F. Welch,et al. Causes and Consequences , 2017, Nature.
[2] R. W. Scarff,et al. THE POSITION OF HISTOLOGY IN THE PROGNOSIS OF CARCINOMA OF THE BREAST. , 1928 .
[3] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.
[4] Causes and consequences , 2021 .
[5] P. Fialkow. Is lyonisation total in man? , 1970, Lancet.
[6] J. Baak,et al. MORPHOMETRY FOR PROGNOSIS PREDICTION IN BREAST CANCER , 1981, The Lancet.
[7] S Friedman,et al. Prognostic value of histologic grade nuclear components of Scarff‐Bloom‐Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas , 1989, Cancer.
[8] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[9] Anthony C. Davison,et al. Bootstrap Methods and Their Application , 1998 .
[10] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[11] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[13] J. Baak,et al. The framework of pathology: good laboratory practice by quantitative and molecular methods , 2002, The Journal of pathology.
[14] Zena Werb,et al. Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.
[15] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[16] R. Tibshirani,et al. Statistical Applications in Genetics and Molecular Biology Pre-validation and inference in microarrays , 2011 .
[17] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[18] Tina Hernandez-Boussard,et al. Determination of Stromal Signatures in Breast Carcinoma , 2005, PLoS biology.
[19] G. Collins. The next generation. , 2006, Scientific American.
[20] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[21] Trevor Hastie,et al. Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers , 2006, PLoS medicine.
[22] C. Sotiriou,et al. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.
[23] G. Sherlock,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.
[24] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[25] Mikhail Teverovskiy,et al. Improved prediction of prostate cancer recurrence through systems pathology. , 2007, The Journal of clinical investigation.
[26] C. Colpaert,et al. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation , 2007, Histopathology.
[27] Gerardo Fernandez,et al. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Rudolf Hanka,et al. Assessing Agreement between Multiple Raters with Missing Rating Information, Applied to Breast Cancer Tumour Grading , 2008, PloS one.
[29] Andrew H. Beck,et al. The fibromatosis signature defines a robust stromal response in breast carcinoma , 2008, Laboratory Investigation.
[30] Laoighse Mulrane,et al. Automated image analysis in histopathology: a valuable tool in medical diagnostics , 2008, Expert review of molecular diagnostics.
[31] T. Sørlie,et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome , 2008, The Journal of pathology.
[32] Trevor Hastie,et al. Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification. , 2008, European journal of cancer.
[33] F. Pépin,et al. Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.
[34] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[35] Yuan Qi,et al. Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[37] Jorge S. Reis-Filho,et al. Molecular Profiling: Moving Away from Tumor Philately , 2010, Science Translational Medicine.
[38] K. Polyak,et al. Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.
[39] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[40] C. Hitchcock,et al. The future of telepathology for the developing world. , 2011, Archives of pathology & laboratory medicine.
[41] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[42] J. Cheng,et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling , 2011, Nature.